Description
NLG919 is an inhibitor of indoleamine-2,3-dioxygenase (IDO). This compound displays anticancer chemotherapeutic activity, prolonging survival rates in animal models of glioblastoma.
Product Unit Size | Cost | Quantity | Stock |
---|
NLG919 is an inhibitor of indoleamine-2,3-dioxygenase (IDO). This compound displays anticancer chemotherapeutic activity, prolonging survival rates in animal models of glioblastoma.
Cas No. | 1402836-58-1 |
---|---|
Purity | ≥98% |
Formula | C18H22N2O |
Formula Wt. | 282.39 |
Chemical Name | 1-Cyclohexyl-2-(5H-imidazo[5,1-a]isoindol-5-yl)ethanol |
IUPAC Name | 1-Cyclohexyl-2-(5H-imidazo[5,1-a]isoindol-5-yl)ethanol |
Synonym | NLG919 (GDC-0919), GTPL9019 |
Solubility | Ethanol 30 mg/mL (106.23 mM) DMSO 15 mg/mL warmed (53.11 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Vacchelli E, Aranda F, Eggermont A, et al. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 2014 Dec 15;3(10):e957994. PMID: 25941578.
Li M, Bolduc AR, Hoda MN, et al. The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma. J Immunother Cancer. 2014 Jul 7;2:21. PMID: 25054064.
Fermentation impurity
PI3K inhibitor, microtubule polymerization inhi...
Kv7 K+ channel activator, NMDA antagonist, GABA...
Azalide macrolide; protein translation inhibito...
HDAC6 inhibitor.
Peptide, c-Kit ligand fragment.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Amino acid precursor of dopamine.
Triterpene saponin found in species of Panax.
Tetracycline; protein translation inhibitor, MM...
HDAC inhibitor. May reduce blood pressure in hy...
Steviol glycoside used as sucrose substitute
TTK/CLK2 inhibitor.
ALK, c-Fes, LRRK2 inhibitor.
Endogenous peptide hormone, involved in cell gr...
ITC, erucin analog.
Coccidiostat, GAPDH inhibitor.
Electrophile used in 2’-hydroxyl acylation of...
AhR agonist, dihydroorotate dehydrogenase inhib...
Non-steroid; AR antagonist.